Galantamine alleviates inflammation and insulin resistance in patients with metabolic syndrome in a randomized trial

BACKGROUND. Metabolic syndrome (MetS) is an obesity-driven condition of pandemic proportions that increases the risk of type 2 diabetes and cardiovascular disease. Pathophysiological mechanisms are poorly understood, though inflammation has been implicated in MetS pathogenesis. The aim of this study...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:JCI Insight
Hlavní autoři: Consolim-Colombo, Fernanda M., Sangaleti, Carine T., Costa, Fernando O., Morais, Tercio L., Lopes, Heno F., Motta, Josiane M., Irigoyen, Maria C., Bortoloto, Luiz A., Rochitte, Carlos Eduardo, Harris, Yael Tobi, Satapathy, Sanjaya K., Olofsson, Peder S., Akerman, Meredith, Chavan, Sangeeta S., MacKay, Meggan, Barnaby, Douglas P., Lesser, Martin L., Roth, Jesse, Tracey, Kevin J., Pavlov, Valentin A.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Clinical Investigation 2017
Témata:
Clinical Medicine
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5518569/
https://ncbi.nlm.nih.gov/pubmed/28724799
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.93340
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky